Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colitis × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 11 Lymphoma, Non-Hodgkin 9 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Neoplasms 4 Melanoma 4 Lymphoma, B-Cell 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Arthritis, Rheumatoid 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia 2 Hematologic Neoplasms 2 Fallopian Tube Neoplasms 2 Cytokine Release Syndrome 2 Craniopharyngioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 COVID-19 2

Interventions

Infliximab 3 vedolizumab 2 Prednisone 2 Methylprednisolone 2 LDP-02 2 Immunoglobulin G 2 Fecal Microbiota Transplantation 2 Disulfides 2 CT-P13 2 tocilizumab 1 prednylidene 1 fish oil triglycerides 1 deltacortene 1 Standard of Care 1 Practice Guidelines as Topic 1 Methylprednisolone Hemisuccinate 1 Loperamide 1 Injections 1 Endoscopy 1 Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601611 2020-04-21

COLAR

Herlev Hospital

Phase NA Completed

Arthritis, Colitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡